Idiopathic Myelofibrosis Developing Isolated Granulocytic Sarcoma with der (1;7)(q10; p10) After Splenectomy and Finally Transforming to Acute Myelogenous Leukemia

References

• Weinstein I. M. Idiopathic myelofibrosis: Historical review, diagnosis and management. Blood Reviews 1991; 5: 98–104
   PubMed Web of Science ®Google Scholar
• Silverstein M. N., Brown A. L., Linman J. W. Idiopathic myeloid metaplasia: Its evolution into acute leukemia. Archives of Internal Medine 1973; 132: 709–712
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A., Don C. A. Myelofibrosis: clinical, hematologic and pathologic study of 110 patients. American Journal of the Medical Sciences 1962; 243: 695–715
   Web of Science ®Google Scholar
• Nieman R. S., Barcos M., Bernard C., Bonner H., Mann R., Riedel R. E., Bennet J. M. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426–1437
   PubMed Web of Science ®Google Scholar
• Ward H. P., Block M. H. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1973; 50: 357–420
   Web of Science ®Google Scholar
• Uehara N., Sawada H., Tashima M., Yamagishi M., Uchino H., Ikai K., Nakashima Y., Haebara H., Hamashima Y. An autopsy case of primary myelofibrosis with skin tumors terminating in leukemic transformation. Japanese Journal of Clinical Hematology 1979; 20: 786–793
   PubMedGoogle Scholar
• Takahashi F., Ikeda A., Kohgo Y., Sasagawa Y., Urushizaki Y., Fukushima M., Kumai R., Niitu Y., Urushizaki I. An autopsy case of primary myelofibrosis with skin tumor terminating in leukemic transformation. Japanese Journal of Clinical Hematology 1986; 27: 349–354
   PubMedGoogle Scholar
• Fukushima T., Uchida M., Iwasaki H., Kamiya K., Tanaka T., Yoshimura T., Sasaki K., Tsutani H., Wano Y., Takayama H., Ueda T., Nakamura T. Blastic crisis of primary myelofibrosis associated with multiple myeloblastomas. Japanese Journal of Clinical Hematology 1990; 31: 95–99
   PubMedGoogle Scholar
• Chervenick P. A. Increase in circulating stem cells in patients with myelofibrosis. Blood 1973; 41: 67–71
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Imamura M., Soga R., Tsuda Y., Maeda S., Iwasaki H., Sugiura M., Ohizumi H., Musashi M., Morioka M., Okabe M., Sakurada K., Kasai M., Miyazaki T. Establishment of a novel granulocytic sarcoma cell line which can adhere to dermal fibroblasts from a patient with granulocytic sarcoma in dermal tissues and myelofibrosis. British Journal of Haematology 1992; 82: 26–31
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Hamada J., Li Y. Q., Shinobu N., Imamura M., Okada F., Takeichi N., Hosokawa M. A possible role of 92kDa type IV collagenase in the extramedullary tumor formation in leukemia. Japanese Journal of Cancer Research 1995; 86: 298–303
   PubMedGoogle Scholar
• Llena J. F., Kawamoto K., Hirano A., Feiring E. H. Granulocytic sarcoma of the central nervous system: initial presentation of leukemia. Acta Neuropathologica(Berl) 1978; 42: 145–147
   PubMed Web of Science ®Google Scholar
• Simpson T. A., Jr, Anderson M. L., Garcia J. H., Barton J. C. Myeloblastoma of the brain. Acta Neuropathologica(Berl) 1989; 78: 444–447
   PubMed Web of Science ®Google Scholar
• Akahashi M., Takagiwa M., Oshimi N., Hagiwara K, Mizoguchi H. A case of primary myelofibrosis terminated in acute megakaryoblastic leukemia. Japanese Journal of Clinical Hematology 1984; 25: 352–358
   PubMedGoogle Scholar
• Yamazaki T., Takahashi K., Matsui S., Nanbu S., Yazaki A., Sasuki K., Inoue H. Primary myelofibrosis showing megakaryobkastic crisis. Japanese Journal of Clinical Hematology 1988; 29: 232–230
   PubMedGoogle Scholar
• Kurashima K., Kawamura Y., Ohka T., Hayashi M., Mat-Suda T. Primary myelofibrosis terminating in megakaryoblastic crisis. Japanese Journal of Medicine 1990; 29: 226–229
   PubMedGoogle Scholar
• Hernandez J. M., San Miguel J. F., Gonzalez M., Orfao A., Canizo M. C., Hernandez J., Lopez Borrasca A. Development of acute leukemia after idiopathic myelofibrosis. Journal of Clinical Pathology 1992; 45: 427–430
   PubMed Web of Science ®Google Scholar
• Pitcock J. A., Reinhard E. H., Justus B. W., Mendelsohn R. S. A clinical and pathological study of seventy cases of myelofibrosis. Annals of Internal Medicine 1962; 57: 73–84
   PubMed Web of Science ®Google Scholar
• Mulder H., Steenbergen J., Haanen C. Clinical course and survival after selective splenectomy in 19 patients with primary myelofibrosis. British Journal of Haematology 1977; 35: 194–427
   Web of Science ®Google Scholar
• Silverstein M. N., ReMine W. H. Splenectomy in myeloid metaplasia. Blood 1979; 53: 515–518
   PubMed Web of Science ®Google Scholar
• Manoharan A. Myelofibrosis: Prognostic factors and treatment. British Journal of Haematology 1988; 69: 295–298
   PubMed Web of Science ®Google Scholar
• Barosi G., Ambrosetti A., Buratti A., Finelli C., Liberato N. L., Quaglini S., Ricetti M. M., Visani G., Tura S., Ascari E. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia 1993; 7: 200–206
   PubMed Web of Science ®Google Scholar
• Petroianu A. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia. International Surgeon 1996; 81: 177–179
   PubMed Web of Science ®Google Scholar
• Petroianu A., Da Silva R. G., Simal C. J. R., De Carvalho D. G., Da Silva R. A.P. Late postoperative follow-up of patients submitted to subtotal splenectomy. The American Surgeon 1997; 63: 732–730
   PubMedGoogle Scholar
• Furukawa Ohnaka H. T., Okada T., Hirai M., Takahashi T., Okada H., Akasaka K. A case of primary myclofibrosis transformed into AMMoL after an extirpation of a huge spleen. Japanese Journal of Clinical Hematology 1986; 27: 349–354
   PubMedGoogle Scholar
• Geraedts J. P.M., Den Ottolander G. J., Ploem J. E., Muntinghe O. G. An identical translocation between chromosome 1 and 7 in three patients with myelofibrosis and myeloid metaplasia. British Journal of Haematology 1980; 44: 569–575
   PubMed Web of Science ®Google Scholar
• Yokoo H., Okada Y., Tominaga K., Tsuji M., Takagi T., Maseki N., Sakurai M., Kaneko Y. der (1:7)(q10: p10) in three patients with malignant hematologic disorders. Japanese Journal of Clinical Hematology 1992; 33: 1829–1830
   PubMedGoogle Scholar